Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Revenue recognition

I'm not sure the example you provided is a good enough one.I go back to the coincidence of the clause being added after the fist Markman.IMO, A big coincidence.

And the disclosure of any contingent license means it is more likely than not to happen.Not sure how such a determination could be made by PTSC.I wouldn't think disclosure of that contingency type is not necessary until the acquisition is definite, not just a possibility.And its been out there for a while.

Got another example?

Opty

Share
New Message
Please login to post a reply